25 May 2012

ValiRx acquires Finnish business

18/08/2011 Ben Jaglom

AIM minnow ValiRx (VAL) has acquired the remaining equity in its Finnish non-trading company ValiFinn.

The drug developer and manufacturer of testing kits for conditions such as chlamydia and the menopause acquired ValiFinn for a 'nominal amount' which it remarks represents 'the initial capital introduced into ValiFinnn.' As a result ValiFinn has become a subsidiary of ValiRx with the company enthusing that it will benefit from the 'favourable environment for regulated medical and clinical studies in the Nordic region.' ValiFinn itself has been awarded a grant by the Finnish government for 55,000 which is to be used for 'regulatory and clinical projects' with ValiRx remarking that there is the 'potential for continued further support' from the Finnish.

Last month ValiRx provided an update on one of its lead drugs, VAL201, in which it established a 'potentially important role for VAL201 in treating hormone induced refractory prostate cancer' according to ValiRx. ValiFinn will be conducting 'the management of certain aspects of VAL201' and will be assisting on the 'regulatory work pertaining to the clinical trials.' ValiRx adds that it has been advised that 'Nordic countries offer a potentially favourable location for its initial hormone regulatory cancer clinical trials.'

ValiRx's Finnish chief executive officer Satu Vainikka enthused that ValiRx was now 'establishing an international presence in the Nordic region' and was 'very grateful for the support we are receiving from the Finnish government.' She described the Nordic region as being a 'favourable environment for drug development' insisting that ValiFinn will lead to the 'accelerated development' of VAL201.

Growth Company Investor last recommended shares in ValiRx following the update on VAL201 at 0.8p with the shares currently trading at 0.68p. The latest news does little to change its fundamental investment prospects, although may be of use with VAL201. We retain our speculative buy rating.

Tags: Business in Finland, Business in the Nordic region, Cancer treatments, Government grants, Personalised medicine

Sector: Pharmaceuticals & Biotechnology

Companies: Valirx

Achieve impressive returns

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena

Click here

Achieve impressive returns on the go

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!

Institutional Investors in AIM 2011 - New Report

This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

If you're interested in business tax updates visit our specialist tax guide website.

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Gulf starts at Sheikh Adi-2 25/05/2012

Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.

Tags: Doing business in Iraq, Drilling on AIM, Oil on AIM

Sector: Oil & Gas Producers

Companies: Gulf Keystone Petroleum

Shell considers Cove 24/05/2012

Oil giant Shell is extending its offer period for Mozambique-focused Cove Energy (COV) after having its bid trumped by Thai government-owned PTT Exploration & Production.

Tags: Bid trumped, Doing business in Mozambique, Oil giants on AIM, Takeovers and bids

Sector: Oil & Gas Producers

Companies: Royal Dutch Shell 'A' , Cove Energy

Roxi reaches 1,360 metres 23/05/2012

Kazakhstan-focused Roxi Petroleum (RXP) has declared that its NK7 well in the Galaz aea has drilled to a depth of 1,360 metres.

Tags: AIM ventures, Doing business in Kazakhstan, Oil on AIM

Cluff Natural Resources joins AIM 22/05/2012

Steered by sector veteran Algy Cluff, North-Sea focused cash shell Cluff Natural Resources (CNR) has joined AIM.

Tags: Entrepreneurs on AIM, Gold mining, Oil and gas on AIM

Red Emperor exercises Shabeel 21/05/2012

Somalia-focused oil explorer Red Emperor Resources (RMP) has exercised its option to take part in the drilling of the Shabeel North well.

Tags: Business in the Puntland, Doing business in Somalia, Drilling for oil & gas, Oil on AIM

Sector: Oil & Gas Producers

Companies: Red Emperor Resources

Heritage happy in Iraq 18/05/2012

Oil concern Heritage Oil (HOIL) has reported its Miran West-3 well in Iraq could deliver 1,000 barrels per day of condensate.

Tags: Doing business in Iraq, Oil on the full list, Oil production, Target depth

Sector: Oil & Gas Producers

Companies: Heritage Oil

More News

Sectors